Epiminder Limited (ASX:EPI)
0.3400
-0.0150 (-4.23%)
At close: Jul 17, 2026
Epiminder Market Cap
Epiminder has a market cap or net worth of 73.56 million as of July 17, 2026.
Market Cap
73.56M
Enterprise Value
-15.94M
Revenue
648.18K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.34
ChartMarket Cap Chart
Since December 1, 2025, Epiminder's market cap has decreased from 283.42M to 73.56M, a decrease of -74.05%. That is a compound annual growth rate of -88.46%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 17, 2026 | 73.56M | -66.67% |
| Dec 31, 2025 | 220.68M | -22.14% |
| Dec 1, 2025 | 283.42M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EMVision Medical Devices | 150.59M |
| Saluda Medical | 129.79M |
| SomnoMed | 100.78M |
| Lumos Diagnostics Holdings | 79.33M |
| Cleo Diagnostics | 49.27M |
| OncoSil Medical | 44.51M |
| HeraMED | 43.98M |
| Compumedics | 43.95M |